Sarepta Therapeutics, Inc., Cambridge, MA, USA.
J Neuromuscul Dis. 2021;8(4):489-494. doi: 10.3233/JND-200622.
Recombinant micro-dystrophin genes are designed to treat Duchenne muscular dystrophy (DMD) by retaining dystrophin domains believed to play key functional roles while fitting the packaging capacity of adeno-associated virus vectors. Domains R1-3 are important for muscle force generation and for association with the sarcolemma, but the nature of this interaction is not fully understood. We measured lipid-binding affinity of 3 peptides containing different spectrin-like repeat modules (R1-3; R1-2; and R1, 2, 22). Lipid-binding affinity was highest with R1-3, suggesting that the complete R1-R3 region could be beneficial and should be considered for inclusion in micro-dystrophin constructs.
重组微肌营养不良蛋白基因旨在通过保留被认为发挥关键功能作用的肌营养不良蛋白结构域来治疗杜氏肌营养不良症(DMD),同时适应腺相关病毒载体的包装能力。结构域 R1-3 对于肌肉力量产生和与肌膜的关联很重要,但这种相互作用的性质尚不完全清楚。我们测量了含有不同 spectrin 样重复模块(R1-3;R1-2;和 R1、2、22)的 3 种肽的脂质结合亲和力。与 R1-3 的结合亲和力最高,这表明完整的 R1-R3 区域可能是有益的,并且应该考虑包含在微肌营养不良蛋白构建体中。